Obvia Pharmaceuticals, LTD.
Madison, WI
- UEI
- E7YPXJPPN8V8
- CAGE
- 9CKB7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 504 S Rosa Rd, Madison, WI 53719, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Increasing immune tolerance in vcas with innovative PRC-210 and identifying new corresponding peripheral biomarker for… | Defense Health Agency | $199,623 | |
| Progressing PRC 210 to clinical treatment for the prevention of neurodegenerative diseases after radiation | Defense Health Agency | $1,081,762 | |
| Novel application of PRC-210 aminothiol free-radical scavenger for the protection of vascularized allotransplants | Defense Health Agency | $1,000,000 |
About Obvia Pharmaceuticals, LTD.
Obvia Pharmaceuticals, LTD. is a for-profit corporate entity that provides pharmaceutical research and development services to the U.S. federal government through prime and sub federal grant awards. Obvia Pharmaceuticals specializes in developing innovative medications and treatments for diseases and injuries commonly affecting military personnel and veterans.
Through prime federal grants from the Defense Health Agency and Department of the Army Medical Command under the Military Medical Research and Development program, Obvia Pharmaceuticals has conducted research on novel pharmaceuticals like PRC-210 to increase immune tolerance in vascularized composite allografts, prevent neurodegenerative diseases after radiation exposure, and protect vascularized allotransplants. As a sub awardee under The Trustees of Columbia University, Obvia Pharmaceuticals also provided services testing the effects of PRC-210 combined with granulocyte colony stimulating factor after radiation exposure in mice. In total, Obvia Pharmaceuticals has been awarded over $2.28 million in federal grants to progress its pharmaceutical research to transform military and public healthcare.
Quick answers
What is Obvia Pharmaceuticals, LTD.'s UEI?
Obvia Pharmaceuticals, LTD.'s Unique Entity ID (UEI) in SAM.gov is E7YPXJPPN8V8.
What is Obvia Pharmaceuticals, LTD.'s CAGE code?
Obvia Pharmaceuticals, LTD.'s CAGE code is 9CKB7.
What is Obvia Pharmaceuticals, LTD.'s primary NAICS code?
Obvia Pharmaceuticals, LTD.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Obvia Pharmaceuticals, LTD. located?
Obvia Pharmaceuticals, LTD.'s physical address in SAM.gov is 504 S Rosa Rd, Madison, WI 53719, USA.
Is Obvia Pharmaceuticals, LTD. registered in SAM.gov?
Yes. Obvia Pharmaceuticals, LTD.'s SAM.gov registration is active through April 14, 2027.
What is Obvia Pharmaceuticals, LTD.'s most recent federal award?
Obvia Pharmaceuticals, LTD.'s most recent federal grant award is Increasing immune tolerance in vcas with innovative PRC-210 and identifying new corresponding peripheral biomarker for… (HT94252311030), from Defense Health Agency, on September 1, 2023.
On GovTribe
See Obvia Pharmaceuticals, LTD.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors